Evidence map›Paper›PMID 42193489›Full record

ArticleBiomedicines2026

Development of Type II Glucose Transporter Inhibitors: Phloretin as a GLUT-2 Screening Template from

Worarat Boonpech, Pemikar Srifa, Dhassida Sooksawat, Praopim Limsakul, Jirakrit Saetang, Varomyalin Tipmanee, Krit Charupanit, Chaitong Churuangsuk, Kantida Juncheed

Abstract read
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Worarat BoonpechInstitute of Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
Pemikar SrifaDepartment of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
Dhassida SooksawatDivision of Physical Science, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
Praopim LimsakulDivision of Physical Science, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.ORCID 0000-0001-7389-4533
Jirakrit SaetangInternational Center of Excellence in Seafood Science and Innovation, Faculty of Agro-Industry, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.ORCID 0000-0003-2769-8149
Varomyalin TipmaneeDepartment of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.ORCID 0000-0001-6017-7519
Krit CharupanitInstitute of Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.ORCID 0000-0002-9803-2005
Chaitong ChuruangsukCenter of Biological Activities Testing, Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.ORCID 0000-0003-4373-6395
Kantida JuncheedInstitute of Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.ORCID 0000-0002-6187-230X

Funding

Faculty of Medicine, Prince of Songkla University REC.65-241-38-2Prince of Songkla University MED6502043S
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer metabolismglucose uptakeGLUT-2GLUT inhibitorshepatocellular carcinomamolecular dockingphloretin

Identifiers

PMID42193489
PMCPMC13204967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.